The store will not work correctly when cookies are disabled.
{4-[6-Amino-5-(4-chlorophenyl)pyridin-3-yl]phenoxy}acetic acid
ID: ALA4779507
PubChem CID: 162663262
Max Phase: Preclinical
Molecular Formula: C19H15ClN2O3
Molecular Weight: 354.79
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ncc(-c2ccc(OCC(=O)O)cc2)cc1-c1ccc(Cl)cc1
Standard InChI: InChI=1S/C19H15ClN2O3/c20-15-5-1-13(2-6-15)17-9-14(10-22-19(17)21)12-3-7-16(8-4-12)25-11-18(23)24/h1-10H,11H2,(H2,21,22)(H,23,24)
Standard InChI Key: TYUVOSCOPCOESA-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
27.7890 -11.1303 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6226 -8.6795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6215 -9.4991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3295 -9.9080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0392 -9.4986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0364 -8.6759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3277 -8.2707 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.7440 -9.9053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7440 -10.7236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4515 -11.1310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1595 -10.7213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1556 -9.8998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4475 -9.4961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7425 -8.2647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9153 -9.9074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2077 -9.4965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5001 -9.9039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4990 -10.7219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2114 -11.1309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9160 -10.7212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8684 -11.1278 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.0820 -10.7205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3736 -11.1279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6666 -10.7181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.3723 -11.9451 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
5 8 1 0
6 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
3 15 1 0
11 21 1 0
18 1 1 0
1 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.79 | Molecular Weight (Monoisotopic): 354.0771 | AlogP: 4.11 | #Rotatable Bonds: 5 |
Polar Surface Area: 85.44 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.80 | CX Basic pKa: 6.03 | CX LogP: 2.11 | CX LogD: 0.85 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.72 | Np Likeness Score: -0.67 |
References
1. Dow RL,Ammirati M,Bagley SW,Bhattacharya SK,Buckbinder L,Cortes C,El-Kattan AF,Ford K,Freeman GB,Guimarães CRW,Liu S,Niosi M,Skoura A,Tess D. (2018) 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety., 61 (7): [PMID:29570292] [10.1021/acs.jmedchem.8b00152] |